Anemia during pregnancy, a worldwide public health problem, is responsible for considerable perinatal morbidity and mortality (20, 21)
Summary: Weight loss injections including semaglutide and liraglutide should not be used during breastfeeding according to UK prescribing guidance due to lack of human safety data
doi: 10.1016/S0378-4290(98)00131-2 CrossRef Full Text | Google Scholar Ross, C., Saggar, S., Yeates, G., Dando, J., and Shepherd, G
Managing Side Effects During the Switch Nausea and appetite suppression tend to be more pronounced with tirzepatide initially, especially in the first 1-2 weeks after starting
A 2017 systematic review found insufficient evidence to recommend their routine use for functional dyspepsia or bloating